Forbes -
28 Feb 2014 17:00
Wall Street is expecting higher profit for PDL BioPharma when the company reports its fourth quarter results on Monday, March 3, 2014. The consensus estimate is calling for profit of 41 cents a share, a rise from 34 cents per share a year ago.For the fiscal year, analysts are expecting
Share this Article
Comment on this Article
Please to comment